Skip to main content

Security Directory

Explore comprehensive security analyses from websites around the world. Filter by industry, location, risk level, and more.

Live Guard activity

Security teams are checking their sites with Guard right now

Run your domain before the queue fills up

0
Websites
0
Industries
0
Countries
0
Avg Score
Page 67 of 127|Showing 3301-3350 of 6317
viatris.lv favicon

Viatris Latvija

viatris.lv

0
HealthcareLatviaenterpriseMEDIUM

Viatris Latvija operates as a local branch of the global pharmaceutical company Viatris Inc., providing high-quality medicines and healthcare solutions tailored to the Latvian market. The website serves multiple audiences including healthcare professionals, patients, investors, and job seekers, offering comprehensive information about products, corporate culture, and investor relations. The site is well-branded and consistent with the global Viatris identity, reflecting a mature enterprise-level business model focused on healthcare delivery and innovation. Technically, the website leverages a modern technology stack including jQuery, Backbone.js, and Sitecore CMS, ensuring a responsive and accessible user experience. The presence of Google Tag Manager indicates active analytics and marketing tracking, balanced with GDPR-compliant privacy and cookie policies. The site demonstrates good SEO and accessibility practices, with clear navigation and localized content in Latvian. From a security perspective, the site enforces HTTPS and avoids exposing sensitive data, but lacks explicit security headers and published security policies or incident response contacts. No vulnerabilities or suspicious domains were detected. The WHOIS data aligns well with the business claims, supporting legitimacy and trustworthiness. Overall, Viatris.lv presents a professional, secure, and compliant digital presence appropriate for a global healthcare company’s local branch. Strategic improvements in security policy transparency and header implementation could further enhance trust and resilience.

20
25
2
60
62
60
100
healthcarepharmaceuticalcorporatelatviaviatris+2 more
jQueryJW PlayerGoogle Tag ManagerModernizr+3

Partner Domains:

www.viatris.com
parent
investor.viatris.com
related

+1 more partners

2025-09-07T11:50:15.533Z
viatris.ee favicon

Viatris

viatris.ee

0
HealthcareEstoniaenterpriseMEDIUM

Viatris Estonia is a regional website for Viatris, a global healthcare company formed in 2020 by the merger of Mylan and Pfizer's Upjohn unit. The company focuses on manufacturing and marketing a broad portfolio of pharmaceutical products across multiple therapeutic areas. The website targets healthcare professionals, patients, and partners in Estonia, providing localized content, contact information, and links to corporate resources. The business model centers on pharmaceutical production and distribution with a strong emphasis on corporate social responsibility and global healthcare access. Technically, the website is built on the Sitecore CMS platform and employs a modern JavaScript technology stack including jQuery and Google Tag Manager for analytics and marketing. The site is mobile optimized, accessible, and SEO friendly, with clear navigation and professional design. Cookie consent and privacy policies are implemented in compliance with GDPR requirements. From a security perspective, the site uses HTTPS and cookie consent mechanisms but lacks explicit security headers and published security policies or incident response contacts. No vulnerabilities or suspicious content were detected. WHOIS data confirms domain legitimacy and consistency with the business claims. Overall, the site demonstrates a mature digital presence with room for improvement in security transparency. The overall risk is low with no critical issues detected. Strategic recommendations include enhancing security headers, publishing a security policy and incident response information, and implementing a vulnerability disclosure program to further strengthen trust and compliance.

20
83
2
60
62
60
100
healthcarepharmaceuticalscorporateestoniaprivacy+2 more
jQueryGoogle Tag ManagerOpenTag (OneTrust) Cookie Consent

Partner Domains:

www.viatris.com
parent
newsroom.viatris.com
related

+3 more partners

2025-09-07T11:49:25.349Z
zentiva.es favicon

Zentiva Group, a.s.

zentiva.es

0
HealthcareSpainlargeMEDIUM

Zentiva Group, a.s. operates a professional and comprehensive pharmaceutical website focused on providing affordable healthcare and pharmaceutical products across multiple countries, primarily in Europe. The company emphasizes innovation, manufacturing, and sustainability in its business model, targeting a broad audience including healthcare professionals and the general public. The website is well-structured, multilingual, and links to numerous country-specific subsidiaries, reflecting a large multinational presence. Technically, the site uses a modern technology stack including jQuery, Google Tag Manager, Cookiebot for consent management, and other JavaScript libraries to enhance user experience and analytics. The site is mobile-optimized, accessible, and SEO-friendly, though some security headers are not explicitly detected. HTTPS is enforced, and cookie consent mechanisms are implemented, indicating good privacy compliance. Security posture is solid with no critical vulnerabilities detected in the content. However, the absence of explicit security policies, incident response contacts, and vulnerability disclosure mechanisms suggests room for improvement in transparency and security maturity. The WHOIS data is unavailable due to query restrictions, but the domain and website content are consistent with a legitimate, established pharmaceutical company. Overall, the website presents a trustworthy, professional front with good compliance and technical standards, suitable for its industry and audience.

70
40
17
60
82
75
100
pharmaceuticalhealthcarecorporategdprcookie-consent+1 more
jQuery 2.2.4Google Tag ManagerCookiebotModernizr+2

Partner Domains:

www.zentiva.com
subsidiary
www.zentiva.bg
subsidiary

+3 more partners

2025-09-07T11:48:15.185Z
zentiva.pt favicon

Zentiva Group, a.s.

zentiva.pt

0
HealthcarePortugallargeMEDIUM

Zentiva Group, a.s. operates a professional and comprehensive website focused on providing quality generic medicines primarily in Portugal and across multiple European and international markets. The company positions itself as a large healthcare entity with a strong emphasis on innovation, production, service, and sustainability. The website content is well-structured, professionally designed, and targets a broad audience including healthcare providers, pharmacies, and the general public. The presence of multiple international subsidiary domains indicates a broad market footprint and corporate maturity. Technically, the website employs a modern technology stack including jQuery, Google Tag Manager, Cookiebot for consent management, and Google Fonts, ensuring good performance and mobile optimization. Accessibility and SEO practices are well implemented, contributing to a positive user experience. The site uses HTTPS with excellent SSL configuration, though explicit security headers could be improved. From a security perspective, the site demonstrates good practices such as HTTPS enforcement and cookie consent mechanisms. However, it lacks a publicly available security policy, incident response contacts, and vulnerability disclosure mechanisms, which are recommended for enhanced trust and compliance. No vulnerabilities or suspicious domains were detected, and no WAF or blocking mechanisms interfere with content access. Overall, Zentiva.pt is a trustworthy, professional, and compliant website representing a reputable pharmaceutical business. Strategic improvements in security headers and transparency around security policies would further strengthen its posture.

70
40
17
85
82
85
100
healthcarepharmaceuticalsgenericmedicinessustainabilitycorporate+1 more
jQuery 2.2.4Google Tag ManagerCookiebotModernizr+2

Partner Domains:

zentiva.com
subsidiary
zentiva.de
subsidiary

+3 more partners

2025-09-07T11:48:00.152Z
zentiva.lt favicon

Zentiva Group, a.s. Lietuvos filialas

zentiva.lt

0
HealthcareLithuanialargeMEDIUM

Zentiva Group, a.s. Lietuvos filialas is a regional branch of the multinational pharmaceutical company Zentiva Group, specializing in the production and distribution of generic medicines. The website targets healthcare professionals and consumers in Lithuania, providing information about their generic pharmaceutical products. The company maintains a strong market position in the healthcare sector with multiple subsidiaries across Europe and beyond. The website content is professionally presented, consistent with the brand, and localized for the Lithuanian market. Technically, the website employs modern web technologies including Google Tag Manager, Cookiebot for consent management, and Google Fonts. The site is mobile-optimized and implements GDPR-compliant cookie consent mechanisms. Performance is moderate with good SEO and basic accessibility features. However, no CMS or hosting provider details are explicitly identified. From a security perspective, the site uses HTTPS and cookie consent best practices but lacks explicit security headers and published security or incident response policies. No vulnerabilities or suspicious content were detected. The absence of WHOIS data limits domain legitimacy verification, but the professional presentation and multinational presence support the site's credibility. Overall, the website presents a low-risk profile with good privacy compliance and business credibility. Strategic improvements include enhancing security headers, publishing security policies, and improving accessibility to further strengthen trust and compliance.

70
100
17
85
82
70
100
pharmaceuticalgenericmedicineshealthcarecookieconsentgdpr+1 more
Google Tag ManagerCookiebotModernizrSelect2+1

Partner Domains:

www.zentiva.com
parent
www.zentiva.bg
subsidiary

+3 more partners

2025-09-07T11:47:45.121Z
zentiva.hu favicon

Zentiva Pharma Kft.

zentiva.hu

0
HealthcareHungarylargeLOW

Zentiva Pharma Kft. is a significant player in the Hungarian generic pharmaceutical market, providing high-quality, affordable medicines to patients. The company operates as part of the larger Zentiva Group, with a broad presence across Europe and India. The website reflects a professional business model focused on pharmaceutical manufacturing and distribution, targeting patients and healthcare providers in Hungary. The site content is well-structured, with clear branding and consistent messaging about their role in the healthcare sector. Technically, the website employs modern web technologies including JavaScript libraries, Google Tag Manager for analytics, and Cookiebot for GDPR-compliant cookie consent management. The site is mobile-optimized and uses HTTPS with strong SSL configuration, ensuring secure communications. Accessibility features are basic but present, and SEO practices are adequately implemented. From a security perspective, the site demonstrates good practices such as HTTPS enforcement, CSRF protection cookies, and a comprehensive cookie consent mechanism. However, it lacks explicit security policies or incident response contact information, and security headers are not visibly configured. No critical vulnerabilities or suspicious content were detected. Overall, the website is trustworthy, compliant with GDPR, and professionally maintained. Strategic improvements could include publishing a security policy, adding Terms of Service, and enhancing security headers to further strengthen the security posture.

70
100
17
85
82
85
100
pharmaceuticalhealthcaregenericmedicinescookieconsentgdprcompliant
JavaScriptGoogle Tag ManagerCookiebotModernizr+2

Partner Domains:

zentiva.com
parent
cookiebot.com
partner
2025-09-07T11:47:25.077Z
V

Vipharm Slovakia s.r.o.

vipharm.sk

0
HealthcareSlovakiamediumHIGH

Vipharm Slovakia s.r.o. is a Slovak branch of a Polish pharmaceutical company specializing in the research, production, and sale of high-quality specialized medicines primarily in neurology, psychiatry, and oncology. The company emphasizes compliance with EU standards and quality assurance throughout its manufacturing processes. Their website serves both healthcare professionals and patients, offering educational content and support services including adverse effect reporting. The company maintains a medium-sized market presence with a focus on specialized pharmaceutical products and patient education initiatives. Technically, the website is built on WordPress 4.1.41 with common plugins such as LayerSlider and Contact Form 7. The technology stack includes older versions of jQuery and lacks modern security headers, indicating moderate digital maturity. The site is moderately optimized for performance and mobile use but could benefit from updates and enhanced accessibility features. From a security perspective, the site uses HTTPS but runs outdated software versions that may expose it to vulnerabilities. No advanced security headers are present, and there is no cookie consent mechanism, which may impact GDPR compliance. Contact information is clearly provided, enhancing business credibility. No signs of malware or phishing were detected. Overall, the website is functional and professional but requires technical and security improvements to enhance its posture and compliance. Strategic updates to software, implementation of security headers, and privacy enhancements are recommended to reduce risk and improve trust.

15
10
2
10
67
75
100
pharmaceuticalhealthcareneurologypsychiatryoncology+2 more
jQuery 1.11.1LayerSlider pluginContact Form 7 pluginSuperfish menu+2

Partner Domains:

pilulka.sk
partner
medseminar.sk
partner
2025-09-07T10:42:13.157Z
T

Teva Slovakia

teva.sk

0
HealthcareSlovakiaenterpriseMEDIUM

Teva Slovakia operates as a pharmaceutical manufacturing and distribution company, specializing in generic, specialty, and over-the-counter medicines. It holds a significant manufacturing facility in Opava producing billions of pharmaceutical units annually, serving over 50 markets including Slovakia. The company emphasizes patient-centric health initiatives and community engagement, positioning itself as a major player in the healthcare sector. The website reflects a professional corporate presence with clear navigation and multilingual support, targeting healthcare professionals and patients alike. Technically, the site employs modern JavaScript libraries, cookie consent management via OneTrust, and monitoring tools such as Microsoft Azure Application Insights and Microsoft Clarity, indicating a mature digital infrastructure. Security posture is solid with HTTPS enforced and monitoring tools in place, though explicit security headers and policies are not prominently published. Privacy compliance is supported by a cookie consent mechanism but lacks visible privacy and terms of service documentation in the provided content. Overall, the domain registration and WHOIS data align well with the corporate identity, supporting legitimacy and trustworthiness.

55
88
2
88
75
70
100
pharmaceuticalhealthcarecorporatecookie-consentanalytics+1 more
jQuery 3.5.1jQuery UI 1.13.2Popper.jsOneTrust Cookie Consent+2

Partner Domains:

www.tevapharm.com
parent
2025-09-07T10:41:27.365Z
canjhealthtechnol.ca favicon

CADTH

canjhealthtechnol.ca

0
HealthcareCanadamediumHIGH

The Canadian Journal of Health Technologies is an open-access scientific and policy journal published by CADTH, the Canadian Agency for Drugs and Technologies in Health. It serves healthcare professionals, policymakers, and researchers by providing timely reimbursement recommendations, reviews, and health technology assessments. The journal operates on a monthly publication cycle and leverages a specialized academic publishing platform to deliver content. The website reflects a professional and consistent brand aligned with its parent organization, CADTH, and targets a Canadian healthcare audience. Technically, the website is built on Open Journal Systems CMS version 3.3.0.8, incorporating modern web technologies such as Google Analytics, Google Tag Manager, Twitter tracking, MathJax for mathematical rendering, and Ionicons for iconography. The site is mobile-optimized with good navigation and SEO practices, though accessibility features are basic. Hosting and domain registration are managed through Rebel.ca, with domain registration details consistent with the organization's identity. From a security perspective, the site uses HTTPS with a good SSL configuration and domain status protections to prevent unauthorized transfers or updates. However, DNSSEC is not enabled, and no security headers were detected, which are areas for improvement. The absence of privacy and cookie policies, as well as incident response or vulnerability disclosure information, indicates gaps in compliance and transparency. Tracking scripts are present, suggesting moderate user tracking without explicit consent mechanisms. Overall, the website is trustworthy, professional, and serves its intended audience well but would benefit from enhanced privacy compliance, security hardening, and transparency measures to improve user trust and regulatory adherence.

20
35
2
70
62
55
40
healthcarejournalacademicopen-accesscadth+1 more
Open Journal Systems 3.3.0.8Google AnalyticsGoogle Tag ManagerTwitter Universal Website Tag+3

Partner Domains:

www.cadth.ca
parent
2025-09-07T10:18:19.170Z
bpsalliance.org favicon

Bio-Process Systems Alliance

bpsalliance.org

0
HealthcareUnited StatesmediumMEDIUM

The Bio-Process Systems Alliance (BPSA) is a well-established international industry association focused on advancing single-use technologies in biopharmaceutical manufacturing. Founded in 2005, it serves a global audience of industry professionals, sponsors, and members by providing resources, technical guides, events, and advocacy to promote safe and sustainable manufacturing practices. The website reflects a mature organization with a clear mission and professional presentation. Technically, the website is built on WordPress with modern plugins and libraries such as Swiper.js and Google Tag Manager. Hosting appears to be on AWS infrastructure, and the site is secured with HTTPS and domain transfer lock. Performance and mobile optimization are good, with accessibility and SEO features well implemented. However, DNSSEC is not enabled, and no cookie consent mechanism is present, which could affect compliance in certain jurisdictions. From a security perspective, the site follows basic best practices including HTTPS and protection against user enumeration. There is no visible security policy or incident response contact information, which is a gap for transparency and readiness. No vulnerabilities or sensitive data exposures were detected. Overall, the security posture is solid but could be improved with enhanced policies and DNSSEC. The overall risk assessment is low, with the website demonstrating high professionalism, trustworthiness, and business credibility. Strategic recommendations include enabling DNSSEC, implementing cookie consent for GDPR compliance, publishing security and incident response policies, and ongoing monitoring of third-party scripts. These steps will enhance security, compliance, and user trust.

15
53
2
70
62
70
100
biopharmaceuticalsingle-usetechnologiesindustryassociationhealthcaremanufacturing+4 more
WordPress 6.8.2WP RocketSwiper.jsGoogle Tag Manager+1
2025-09-07T09:15:52.252Z
mabion.eu favicon

Mabion

mabion.eu

0
HealthcarePolandmediumMEDIUM

Mabion is a European Contract Development and Manufacturing Organization (CDMO) specializing in biologics pharmaceutical services. The company offers a comprehensive suite of end-to-end services including drug substance manufacturing, fill & finish, gene to vial development, process development, analytics, and cell line development & banking. Positioned as a trusted partner for pharma and biotech companies, Mabion emphasizes high-quality standards, innovation, and client-centric solutions. The company is headquartered in Poland, strategically located in the heart of Europe, and benefits from European Union funding and recognized certifications such as GMP, GCP, and ISO. Technically, the Mabion website is built on WordPress using the Veneo theme, incorporating modern JavaScript libraries like Swiper and LazyLoad for enhanced user experience and performance. The site is mobile-optimized, fast-loading, and SEO-friendly, with comprehensive metadata and structured data for improved search visibility. Security measures include HTTPS enforcement, strong security headers, and secure contact forms with reCAPTCHA integration. From a security perspective, Mabion demonstrates a mature posture with no visible vulnerabilities or exposed sensitive data. Privacy compliance is robust, featuring a detailed privacy policy, cookie consent mechanisms, and GDPR adherence. However, explicit security policies and incident response information are not publicly available, representing an area for improvement. Overall, Mabion presents a professional, trustworthy, and well-maintained digital presence aligned with its business objectives. The lack of WHOIS transparency is mitigated by strong on-site trust signals and consistent business information. Strategic recommendations include publishing security policies, vulnerability disclosure channels, and data protection officer contacts to further enhance trust and compliance.

15
28
17
100
47
85
100
cdmopharmabiologicshealthcarecontractmanufacturing+2 more
WordPressGoogle Tag ManagerGoogle AnalyticsContact Form 7+2
2025-09-07T09:12:09.446Z
ipa-india.org favicon

Indian Pharmaceutical Alliance

ipa-india.org

0
HealthcareIndialargeMEDIUM

The Indian Pharmaceutical Alliance (IPA) is a prominent industry alliance representing 23 leading Indian pharmaceutical companies. Established in 1999, IPA focuses on policy advocacy, innovation promotion, quality standards, and expanding the global reach of Indian pharmaceuticals. The website reflects a mature digital presence built on Drupal 11, featuring rich content including reports, articles, and multimedia resources. The organization maintains a strong social media footprint and positions itself as a key influencer in pharmaceutical policy and industry standards in India and globally. Technically, the website employs modern web technologies including jQuery, Bootstrap, and slick carousel for enhanced user experience. It is mobile-optimized and accessible with good SEO practices. Security posture is solid with HTTPS enforced and secure form validation, though it lacks some advanced security headers and explicit incident response information. Privacy compliance is partial, with a privacy policy present but no cookie consent mechanism or detailed GDPR compliance statements. Overall, the IPA website demonstrates a high level of professionalism and trustworthiness, consistent with its role as a leading pharmaceutical industry alliance. The lack of WHOIS registrant details is mitigated by the domain's age and alignment with the organization's identity. Strategic recommendations include enhancing privacy compliance, adding security headers, and publishing incident response and vulnerability disclosure policies to further strengthen trust and security.

40
53
25
75
82
70
20
pharmaceuticalhealthcarepolicyinnovationindia+1 more
Drupal 11jQuery 3.7.1Slick CarouselFancybox+3

Partner Domains:

pageindia.org
partner
2025-09-07T09:11:37.833Z
canadianbiosimilarsforum.ca favicon

Canadian Biosimilars Forum

canadianbiosimilarsforum.ca

0
HealthcareCanadasmallMEDIUM

The Canadian Biosimilars Forum is a Canadian alliance representing companies across the biosimilars industry, focused on increasing awareness, access, and adoption of biosimilars nationwide. Their website serves as an informational and advocacy platform, targeting healthcare professionals, policymakers, and patients interested in biosimilars. The organization positions itself as a key industry advocate with a focus on education and policy influence. Technically, the website is built on the Squarespace platform, leveraging modern web technologies including Google Tag Manager and Google Analytics for tracking. The site is mobile-optimized with good design quality and clear navigation, though accessibility features are basic. Performance is moderate, typical of CMS-hosted sites. From a security perspective, the site enforces HTTPS and avoids exposing sensitive data. However, it lacks several security headers and does not publish a privacy policy or cookie consent mechanism, which are important for compliance with privacy regulations such as GDPR. No incident response or security policy information is available, indicating room for improvement in transparency and security posture. Overall, the site is professional and trustworthy with a strong business credibility score. The absence of WHOIS data limits domain registration transparency but is consistent with privacy protection norms. Strategic recommendations include implementing privacy and cookie policies, adding security headers, and publishing security and incident response information to enhance trust and compliance.

35
35
17
70
62
75
100
biosimilarshealthcarecanadapharmaceuticalsadvocacy+1 more
SquarespaceGoogle Tag ManagerGoogle AnalyticsTypekit Fonts
2025-09-07T09:11:02.302Z
B

British Generic Manufacturers Association Ltd trading as Medicines UK

britishbiosimilars.co.uk

0
HealthcareUnited KingdommediumHIGH

Medicines UK, operating as the British Generic Manufacturers Association Ltd, is a UK-based trade association focused on the generic and biosimilar medicines sector. Their British Biosimilars Association (BBA) sector group promotes access to high quality biosimilar medicines, collaborating with healthcare professionals, regulators, and the NHS to support sustainable use and education. The website content is professional and targeted at healthcare stakeholders and patients interested in biosimilars. The technical infrastructure relies on legacy JavaScript libraries such as jQuery 1.11.3 and jQuery UI 1.11.4, with additional UI components like Swiper and Magnific Popup. The site is moderately optimized for mobile and performance but lacks modern CMS or advanced frameworks. No forms or analytics scripts were detected, indicating a low data collection footprint. Security posture is moderate with HTTPS implied but no explicit security headers detected in the provided data. The absence of WHOIS domain registration data is a concern for transparency and trust, although the website content and business information appear legitimate. Privacy compliance is partial, with a privacy policy present but no cookie consent mechanism visible. Overall, the website presents a professional front for a healthcare trade association but would benefit from improved domain transparency, enhanced security headers, and stronger privacy compliance measures.

15
53
2
70
-
75
20
biosimilarshealthcaretradeassociationmedicinesuk+1 more
jQuery 1.11.3jQuery UI 1.11.4SwiperMagnific Popup+1
2025-09-07T09:10:57.238Z
gabionline.net favicon

Generics and Biosimilars Initiative

gabionline.net

0
HealthcareN/amediumMEDIUM

The Generics and Biosimilars Initiative (GaBI) operates a well-established online platform providing comprehensive news, research, and policy information focused on generic and biosimilar medicines. Founded in 2008, the website serves healthcare professionals, pharmaceutical industry stakeholders, and policy makers with up-to-date editorial content and specialized resources. The platform maintains a strong market position as a niche media provider in the healthcare sector, emphasizing cost-effective treatment options. Technically, the website leverages a mature technology stack including IBEXA CMS, Bootstrap, YUI, and jQuery, supported by Google Fonts and Font Awesome for design consistency. Hosting is provided by Hosting Concepts B.V., with domain registration dating back to 2008, indicating a stable digital presence. The site is mobile-optimized and demonstrates good SEO practices, although some modernization opportunities exist, such as updating jQuery and enabling DNSSEC. From a security perspective, the site uses HTTPS and has domain transfer protections in place. However, it lacks DNSSEC and explicit security headers, and no published security or incident response policies were found. Cookie consent is implemented, and privacy policies are comprehensive and GDPR compliant. No critical vulnerabilities or suspicious content were detected, and the site maintains a high trustworthiness rating. Overall, GaBI presents a professional, secure, and privacy-conscious web presence suitable for its target audience. Strategic improvements in security headers, DNSSEC, and incident response transparency could further enhance its security posture and trustworthiness.

15
53
17
60
42
75
100
healthcarepharmaceuticalsgenericsbiosimilarsnews+2 more
YUI 3.17.2jQuery 1.10.2BootstrapFont Awesome+3
2025-09-07T09:10:52.223Z
centerforbiosimilars.com favicon

Center for Biosimilars

centerforbiosimilars.com

0
HealthcareUnited StatesmediumMEDIUM

The Center for Biosimilars is a specialized healthcare information platform focused on providing professionals with insights on biosimilars, health economics, regulatory outcomes, and emerging treatment paradigms. Founded in 2016 and operated under MJH Life Sciences, the website serves a niche audience of healthcare professionals and biosimilar industry stakeholders. The platform offers news, analysis, and educational content relevant to the biosimilars market. Technically, the website leverages modern web technologies including React and Next.js frameworks, with integrations for analytics and consent management such as Google Analytics, Segment, Algolia Insights, and OneTrust. The site demonstrates good mobile optimization and SEO practices, although some accessibility features could be enhanced. Performance is moderate, with a well-structured and professional design. From a security perspective, the site enforces HTTPS and uses consent management for cookies and tracking. However, it lacks explicit security headers and publicly available security policies or incident response contacts. The absence of WHOIS data for the domain raises some concerns about domain registration legitimacy, although the professional content and known parent company mitigate this risk. Overall, the website presents a credible and professional front for its business niche but would benefit from improved transparency in domain registration, explicit privacy and security policies, and enhanced security header implementation to strengthen trust and compliance.

30
88
17
70
-
85
100
biosimilarshealthcarebiosimilardrugshealtheconomicsregulatoryoutcomes+1 more
Next.jsReactGoogle Tag ManagerGoogle Analytics+4
2025-09-07T09:10:42.082Z